Osage Partners related stories
All articles and analysis
Harbert Growth, Ascent Venture, Osage Venture lead $11 mln funding in SidecarHarbert Growth Partners joined Ascent Venture Partners and Osage Venture Partners in an $11 million Series C funding in e-commerce marketing company Sidecar. Other investors in the round included The Yard Ventures, a Harvard alumni venture fund, and Silicon Valley Bank, which provided debt financing. Sidecar has raised $26 million in less than three years.
- SiFive raises $8.5 mln
SiFive said May 8 that it has raised $8.5 million in a Series B round led by Spark Capital. Osage University Partners and existing investor Sutter Hill Ventures also participated. SiFive, of San Francisco, is a fabless provider of open-source-enabled semiconductors.
- Osage University Partners promotes one and hires another
Osage University Partners has promoted Dr. Manny Stockman to senior associate on the tech investment team. Also, the venture firm has hired Dr. Anurag Agarwal on its life science investment team.
- Spero Therapeutics snags $51.7 mln in GV-led round
Cambridge, Massachusetts-based Spero Therapeutics LLC, a biopharmaceutical company focused on developing treatments for bacterial infections, has closed $51.7 million in Series C financing. GV led the round with participation from other investors that included RA Capital Management, Rock Springs Capital, Atlas Venture, MRL Ventures Fund, Lundbeckfonden Ventures, The Kraft Group and Osage University Partners.
- Biohaven closes second tranche of $80 mln private placement
Biohaven Pharmaceutical Holding Company Ltd, a clinical stage biopharmaceutical company targeting neurological diseases, including rare disorders, has closed the second tranche of its $80 million private placement. Venrock was the lead investor. Other participants in the financing included Vivo Capital, RA Capital Management, Aisling Capital, Rock Springs Capital, John W. Childs, Greg Bailey, Knoll Capital Management, Osage University Partners, Aperture Venture Partners, Connecticut Innovations and Litmore Capital.
- PMV Pharma bags $74 mln Series B
Cranbury, New Jersey-based PMV Pharmaceuticals Inc, a developer of small molecule drugs that treat cancer, has closed $74 million in Series B financing. Topspin Biotech Fund led the round with participation from Euclidean Capital, InterWest Partners, OrbiMed Advisors and Osage University Partners.
- Osage promotes Lee to principal
Osage University Partners has promoted John Lee to principal. Lee first joined the Philadelphia-based venture firm in 2012. Prior to joining Osage, Lee worked at Lux Capital and Asia conglomerate Mahindra & Mahindra's investment arm.
- Fortis Therapeutics rakes in $18 mln Series A
San Diego-based Fortis Therapeutics Inc, an immuno-oncology biotech company, has raised $18 million in Series A financing. Avalon Ventures led the round with participation from Bregua Corp, Lilly Asia Ventures, Osage University Partners and Vivo Capital.
- Rackware bags $10 mln in Signal Peak-led round
Fremont, California-based Rackware, a provider of cloud computing management solutions for businesses, has raised $10 million in Series B funding. Signal Peak Ventures led the round with participation from Kickstart Seed Fund and Osage Venture Partners.
IPO Profiles: Six venture-backed companies went IPO in JuneTwilio's debut sparks hope that more tech IPOs are forthcoming